.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Express Scripts
Boehringer Ingelheim
Harvard Business School
Accenture
UBS
Novartis
Farmers Insurance
McKinsey

Generated: December 14, 2017

DrugPatentWatch Database Preview

RAU-SED Drug Profile

« Back to Dashboard

Which patents cover Rau-sed, and when can generic versions of Rau-sed launch?

Rau-sed is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in RAU-SED is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
Drug patent expirations by year for RAU-SED

Medical Subject Heading (MeSH) Categories for RAU-SED

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Bristol Myers SquibbRAU-SEDreserpineTABLET;ORAL009357-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbRAU-SEDreserpineTABLET;ORAL009357-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbRAU-SEDreserpineTABLET;ORAL009357-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Bristol Myers SquibbRAU-SEDreserpineTABLET;ORAL009357-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Healthtrust
Covington
Citi
Medtronic
Accenture
Cerilliant
Queensland Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot